John Reed

John Reed

Director/Board Member at MADRIGAL PHARMACEUTICALS, INC.

Net worth: 7 M $ as of 2026-07-30

67 year
Health Technology
Consumer Services
Commercial Services

Profile

John C. Reed founded Idun Pharmaceuticals, Inc. and Apoptos, Inc. Currently, Dr. Reed is EVP & Global Head-Research & Development at Sanofi and President at Principia Biopharma, Inc. and President & Director at Synthorx, Inc. (both are subsidiaries of Sanofi). He is also on the board of BIOCOM. In his past career John C. Reed occupied the position of Head-Roche Pharma Research & Early Development at Roche Holding AG, President, Chief Executive Officer & Professor at Sanford Burnham Prebys Medical Discovery Institute, Assistant Director at the University of Pennsylvania, Associate Member at the University of California San Diego and Associate Member at Whitaker Institute of Biomedical Engineering. He received an undergraduate degree from the University of Virginia and a doctorate from Perelman School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-30 24,911 ( 0% ) 6 M $ 2026-07-30
2026-08-14 647 ( 0% ) 302 356 $ 2026-07-30

John Reed active positions

CompaniesPositionStart
JOHNSON & JOHNSON Corporate Officer/Principal -
MADRIGAL PHARMACEUTICALS, INC. Director/Board Member 2026-08-10

Former positions of John Reed

CompaniesPositionEnd
SANOFI Chief Tech/Sci/R&D Officer 2023-02-12
ROCHE HOLDING AG Corporate Officer/Principal 2018-04-01
CLOVIS ONCOLOGY, INC. Director/Board Member 2013-02-13
IONIS PHARMACEUTICALS, INC. Director/Board Member 2013-02-11
Corporate Officer/Principal 2012-12-31
See the detail of John Reed's experience

Training of John Reed

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

93

1st degree connections

21

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies21

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Commercial Services

Health Services

Commercial Services

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology